Business Description
Sirnaomics is a drug development company focused on RNA-based medicines, primarily serving patients in China. Founded in 2007 and based in Germantown, Maryland, the company is working on treatments for a wide range of conditions, including several types of cancer, heart and metabolic diseases, blood clotting disorders, and certain skin conditions. Its most advanced drug candidates target non-melanoma skin cancer and head and neck cancer, with additional programs addressing rare and complex diseases across multiple therapeutic areas.
